Should we start measuring lipids from now, year 2016?

Ever since in the year 2013, American guidelines focused on atherosclerotic cardiovascular disease as a prime focus for treating lipids. Measuring lipids in patients became a less important. More than that clinicians had only statins at their disposal for treating
Read the rest

Impact of ATP4 guidelines on non statin drugs in lipid management

ATP4 which is published in Nov 2013 came up with huge change in lipid guidelines. ATP 4 has focused on atherosclerotic events i.e. MI and stroke rather than surrogates like LDL HDL Triglycerides values. 
Lipid level treatment and atherosclerosis events
Read the rest

Drug price control of statin may not useful as per new guidelines

There is a paradigm shift in treatment of patient for prevention of atherosclerotic disease and management of cholesterol as per new guide lines i.e. ATP 4 2013. In these new guidelines there are no targets to which cholesterol need to
Read the rest

High intestinal absorption of cholesterol versus synthesis of cholesterol in CAD risk.

Statins reduces the cholesterol effectively in patients with increased synthesis of cholesterol; they cannot reduce level of cholesterol in patients with increased intestinal absorption of cholesterol. Many studies have shown that ,increase ratio of absorption of cholesterol to serum level

Read the rest

Quality of fat by CT scan to predict cardiovascular risk

It is known that adipose tissue of body i.e. visceral adipose tissue (VAT) is associated increased cardiovascular risk than subcutaneous adipose tissue (SAT). The more the adipose tissue, more the risk of cardiovascular disease. Adipose tissue by CT scan has

Read the rest

Antisense oligonucleotides technology for reducing triglyceride

Gene expression occurs through formation of messenger RNA (mRNA) synthesized from gene DNA. Oligonucleotidesare small fragments of nucleic acid which can be used as therapeutic agents. In Antisense technology complimentary oligonucleotides are created to mRNA of interest, so this
Read the rest